Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
ABVX
ABVX News & Events
-
Add to Watchlist
Trade ABVX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ABVX News
Investing in Clinical-Stage Biotechs: Risks and Opportunities
14h ago
Fool
Reasons Behind Abivax's 1000% Stock Surge
Feb 27 2026
Fool
Abivax Presents New Findings on Obefazimod at ECCO Congress
Feb 21 2026
NASDAQ.COM
Abivax Presents Obefazimod's First Evidence of Anti-Fibrotic Activity
Feb 21 2026
Newsfilter
Eli Lilly's Decade of Market Dominance
Feb 11 2026
Fool
Eli Lilly Sets High Bar, Competitors Follow Suit
Feb 11 2026
NASDAQ.COM
Investment Comparison: AbbVie vs. Abivax
Jan 30 2026
Fool
Market Competition Analysis: AbbVie vs. Abivax
Jan 30 2026
NASDAQ.COM
Show More News
ABVX Events
No data
ABVX Monitor News
Abivax SA stock rises after crossing above 5-day SMA
Mar 10 2026
Abivax's obefazimod shows promise in phase 3 trials
Mar 04 2026
Abivax's stock declines amid market weakness despite promising obefazimod trials
Mar 02 2026
Abivax presents promising obefazimod data at ECCO 2026
Feb 26 2026
Abivax presents promising obefazimod data at ECCO 2026
Feb 24 2026
Abivax's obefazimod shows promise in phase 3 trials
Feb 06 2026
Abivax's Acquisition Potential and Drug Progress Drive Stock Surge
Jan 20 2026
Eli Lilly Plans €15 Billion Acquisition of Abivax
Jan 15 2026
Show More Monitor News
ABVX Earnings Analysis
No Data
People Also Watch
